Subject
Toxicology,General Medicine
Reference19 articles.
1. Addendum to ICH M7: Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk, 2015.
2. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses;Amberg;Regul. Toxicol. Pharmacol.,2016
3. Establishing best practise in the application of expert review of mutagenicity under ICH M7;Barber;Regul. Toxicol. Pharmacol.,2015
4. In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey;Dobo;Regul. Toxicol. Pharmacol.,2012
5. Assessment of predictivity of semiquantitative risk assessment tool: pazopanib hydrochloride genotoxic impurities;Elder;Org. Process Res. Dev.,2013
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献